122 related articles for article (PubMed ID: 1480321)
1. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat.
Park CK; McCulloch J; Kang JK; Choi CR
Neurosci Lett; 1992 Nov; 147(1):41-4. PubMed ID: 1480321
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.
Park CK; McCulloch J; Kang JK; Choi CR
Acta Neurochir (Wien); 1994; 127(3-4):220-6. PubMed ID: 7942207
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
Chen M; Bullock R; Graham DI; Frey P; Lowe D; McCulloch J
Ann Neurol; 1991 Jul; 30(1):62-70. PubMed ID: 1834008
[TBL] [Abstract][Full Text] [Related]
4. Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
Bullock R; Graham DI; Chen MH; Lowe D; McCulloch J
J Cereb Blood Flow Metab; 1990 Sep; 10(5):668-74. PubMed ID: 2166743
[TBL] [Abstract][Full Text] [Related]
5. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
6. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study.
Sauer D; Allegrini PR; Cosenti A; Pataki A; Amacker H; Fagg GE
J Cereb Blood Flow Metab; 1993 Jul; 13(4):595-602. PubMed ID: 8100238
[TBL] [Abstract][Full Text] [Related]
8. Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.
Jiang N; Zhang RL; Baron BM; Chopp M
J Neurol Sci; 1996 Jun; 138(1-2):36-41. PubMed ID: 8791236
[TBL] [Abstract][Full Text] [Related]
9. Experimental stroke and neuroprotection in the aging rat brain.
Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
Stroke; 1995 Jun; 26(6):1072-8. PubMed ID: 7762026
[TBL] [Abstract][Full Text] [Related]
10. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
11. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
[TBL] [Abstract][Full Text] [Related]
12. Focal ischemic damage is reduced by CPP-ene studies in two animal models.
Bullock R; McCulloch J; Graham DI; Lowe D; Chen MH; Teasdale GM
Stroke; 1990 Nov; 21(11 Suppl):III32-6. PubMed ID: 2146780
[TBL] [Abstract][Full Text] [Related]
13. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on focal cerebral ischemia in cat.
Okada M; Ueda H; Kometani M; Nakao K
Arzneimittelforschung; 1997 Jun; 47(6):703-5. PubMed ID: 9239446
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of D- and L-(E)-4-(3-phosphono-2-propenyl)piperazine-2-carboxylic acid as anticonvulsants and as inhibitors of potassium-evoked increases in hippocampal extracellular glutamate and aspartate levels in freely moving rats.
Millan MH; Chapman AG; Meldrum BS
J Neurochem; 1994 Jan; 62(1):217-22. PubMed ID: 7903351
[TBL] [Abstract][Full Text] [Related]
15. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia.
Hayward NJ; McKnight AT; Woodruff GN
Eur J Neurosci; 1993 Jul; 5(7):961-7. PubMed ID: 8281306
[TBL] [Abstract][Full Text] [Related]
18. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
19. Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
Park CK; McCulloch J; Jung DS; Kang JK; Choi CR
Acta Neurochir Suppl (Wien); 1994; 60():279-81. PubMed ID: 7976566
[TBL] [Abstract][Full Text] [Related]
20. The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the rat.
Tsuchida E; Bullock R
J Neurotrauma; 1995 Jun; 12(3):279-88. PubMed ID: 7473802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
